Jacqualyn A Fouse - Net Worth and Insider Trading

Jacqualyn A Fouse Net Worth

The estimated net worth of Jacqualyn A Fouse is at least $6 Million dollars as of 2024-05-26. Jacqualyn A Fouse is the Director of Agios Pharmaceuticals Inc and owns about 137,396 shares of Agios Pharmaceuticals Inc (AGIO) stock worth over $4 Million. Jacqualyn A Fouse is also the see remarks of Celgene Corp and owns about 18,664 shares of Celgene Corp (CELG) stock worth over $2 Million. Details can be seen in Jacqualyn A Fouse's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jacqualyn A Fouse has not made any transactions after 2024-04-10 and currently still holds the listed stock(s).

Transaction Summary of Jacqualyn A Fouse

To

Jacqualyn A Fouse Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jacqualyn A Fouse owns 5 companies in total, including Incyte Corp (INCY) , Dick's Sporting Goods Inc (DKS) , and Bunge Global SA (BG) among others .

Click here to see the complete history of Jacqualyn A Fouse’s form 4 insider trades.

Insider Ownership Summary of Jacqualyn A Fouse

Ticker Comapny Transaction Date Type of Owner
INCY Incyte Corp 2017-11-14 director
DKS Dick's Sporting Goods Inc 2014-04-03 director
BG Bunge Global SA 2009-09-02 Chief Financial Officer
2024-04-10 director
2013-12-18 director

Jacqualyn A Fouse Latest Holdings Summary

Jacqualyn A Fouse currently owns a total of 2 stocks. Among these stocks, Jacqualyn A Fouse owns 137,396 shares of Agios Pharmaceuticals Inc (AGIO) as of April 10, 2024, with a value of $4 Million and a weighting of 68.18%. Jacqualyn A Fouse also owns 18,664 shares of Celgene Corp (CELG) as of May 21, 2012, with a value of $2 Million and a weighting of 31.82%.

Latest Holdings of Jacqualyn A Fouse

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AGIO Agios Pharmaceuticals Inc 2024-04-10 137,396 31.50 4,327,974
CELG Celgene Corp 2012-05-21 18,664 108.24 2,020,191

Holding Weightings of Jacqualyn A Fouse


Jacqualyn A Fouse Form 4 Trading Tracker

According to the SEC Form 4 filings, Jacqualyn A Fouse has made a total of 5 transactions in Agios Pharmaceuticals Inc (AGIO) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in Agios Pharmaceuticals Inc is the sale of 7,791 shares on April 10, 2024, which brought Jacqualyn A Fouse around $214,642.

According to the SEC Form 4 filings, Jacqualyn A Fouse has made a total of 0 transactions in Celgene Corp (CELG) over the past 5 years. The most-recent trade in Celgene Corp is the acquisition of 2,000 shares on May 21, 2012, which cost Jacqualyn A Fouse around $68,920.

Insider Trading History of Jacqualyn A Fouse

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jacqualyn A Fouse Trading Performance

GuruFocus tracks the stock performance after each of Jacqualyn A Fouse's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jacqualyn A Fouse is 16.53%. GuruFocus also compares Jacqualyn A Fouse's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jacqualyn A Fouse within 3 months outperforms 6 times out of 7 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jacqualyn A Fouse's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jacqualyn A Fouse

Average Return

Average return per transaction

Outperforming Transactions

7 out of 7 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.88
Relative Return to S&P 500(%) 6.34

Jacqualyn A Fouse Ownership Network

Ownership Network List of Jacqualyn A Fouse

No Data

Ownership Network Relation of Jacqualyn A Fouse


Jacqualyn A Fouse Owned Company Details

What does Incyte Corp do?

Who are the key executives at Incyte Corp?

Jacqualyn A Fouse is the director of Incyte Corp. Other key executives at Incyte Corp include EVP & Chief Medical Officer Steven H Stein , EVP GPS & BD & & Licensing Vijay K Iyengar , and Principal Accounting Officer Thomas Tray .

Incyte Corp (INCY) Insider Trades Summary

Over the past 18 months, Jacqualyn A Fouse made no insider transaction in Incyte Corp (INCY). Other recent insider transactions involving Incyte Corp (INCY) include a net sale of 57,275 shares made by Steven H Stein , a net sale of 24,981 shares made by Vijay K Iyengar , and a net sale of 2,500 shares made by Thomas Tray .

In summary, during the past 3 months, insiders sold 0 shares of Incyte Corp (INCY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 155,648 shares of Incyte Corp (INCY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 155,648 shares.

Incyte Corp (INCY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Incyte Corp Insider Transactions

No Available Data

Jacqualyn A Fouse Mailing Address

Above is the net worth, insider trading, and ownership report for Jacqualyn A Fouse. You might contact Jacqualyn A Fouse via mailing address: C/o Dick's Sporting Goods, 345 Court Street, Coraopolis Pa 15108.

Discussions on Jacqualyn A Fouse

No discussions yet.